Cyberknife with fiducial tracking for inoperable peripheral stage I Non-Small cell lung cancer (NSCLC): Locoregional control and overall survival outcomes

Brian T. Collins, Eric K. Oermann, Shaan Kataria, Catherine Jamis, Saloomeh Vahdat, Leonard Chen, Simeng Suy, Sean P. Collins, Eric Anderson

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Associated comorbidities or advanced age prevent many patients with clinical stage I non-small cell lung carcinoma (NSCLC) from undergoing surgery. For patients such as these, the CyberKnife and its use of fiducial tracking may provide the optimal treatment. In this chapter we will provide a brief overview of Georgetown University Hospital's current treatment approach using the CyberKnife. We will also review its mature outcomes for inoperable stage I NSCLC patients that were treated with the CyberKnife and fiducial tracking.

Original languageEnglish
Title of host publicationThe Revolution of Robotic Stereotactic Radiotherapy (Robotic Radiosurgery) in Lung Cancer
PublisherNova Science Publishers, Inc.
Pages133-141
Number of pages9
ISBN (Electronic)9781633212787
ISBN (Print)9781628087185
StatePublished - 1 Jul 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'Cyberknife with fiducial tracking for inoperable peripheral stage I Non-Small cell lung cancer (NSCLC): Locoregional control and overall survival outcomes'. Together they form a unique fingerprint.

Cite this